Literature DB >> 28384479

Mutant Huntingtin Disrupts the Nuclear Pore Complex.

Jonathan C Grima1, J Gavin Daigle2, Nicolas Arbez3, Kathleen C Cunningham4, Ke Zhang2, Joseph Ochaba5, Charlene Geater5, Eva Morozko5, Jennifer Stocksdale5, Jenna C Glatzer2, Jacqueline T Pham6, Ishrat Ahmed7, Qi Peng7, Harsh Wadhwa8, Olga Pletnikova9, Juan C Troncoso10, Wenzhen Duan11, Solomon H Snyder3, Laura P W Ranum12, Leslie M Thompson5, Thomas E Lloyd13, Christopher A Ross3, Jeffrey D Rothstein14.   

Abstract

Huntington's disease (HD) is caused by an expanded CAG repeat in the Huntingtin (HTT) gene. The mechanism(s) by which mutant HTT (mHTT) causes disease is unclear. Nucleocytoplasmic transport, the trafficking of macromolecules between the nucleus and cytoplasm, is tightly regulated by nuclear pore complexes (NPCs) made up of nucleoporins (NUPs). Previous studies offered clues that mHTT may disrupt nucleocytoplasmic transport and a mutation of an NUP can cause HD-like pathology. Therefore, we evaluated the NPC and nucleocytoplasmic transport in multiple models of HD, including mouse and fly models, neurons transfected with mHTT, HD iPSC-derived neurons, and human HD brain regions. These studies revealed severe mislocalization and aggregation of NUPs and defective nucleocytoplasmic transport. HD repeat-associated non-ATG (RAN) translation proteins also disrupted nucleocytoplasmic transport. Additionally, overexpression of NUPs and treatment with drugs that prevent aberrant NUP biology also mitigated this transport defect and neurotoxicity, providing future novel therapy targets.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C9ORF72; Huntington’s disease; KPT-350; O-GlcNAc; RAN translation; Thiamet-G; induced pluripotent stem cell; neurodegeneration; nuclear pore complex; nucleocytoplasmic transport

Mesh:

Substances:

Year:  2017        PMID: 28384479      PMCID: PMC5595097          DOI: 10.1016/j.neuron.2017.03.023

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  61 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  The Ran GTPase as a marker of chromosome position in spindle formation and nuclear envelope assembly.

Authors:  Martin Hetzer; Oliver J Gruss; Iain W Mattaj
Journal:  Nat Cell Biol       Date:  2002-07       Impact factor: 28.824

3.  Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.

Authors:  Wyan-Ching Mimi Lee; Motojiro Yoshihara; J Troy Littleton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

4.  Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.

Authors:  Elisabeth M Chalovich; Jian-hui Zhu; John Caltagarone; Robert Bowser; Charleen T Chu
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

5.  Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.

Authors:  I Ferrer; R Blanco; M Carmona; B Puig; M Barrachina; C Gómez; S Ambrosio
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

6.  Polyglutamine expansion of huntingtin impairs its nuclear export.

Authors:  Jonathan Cornett; Fengli Cao; Chuan-En Wang; Christopher A Ross; Gillian P Bates; Shi-Hua Li; Xiao-Jiang Li
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

Review 7.  Cell signaling, the essential role of O-GlcNAc!

Authors:  Natasha E Zachara; Gerald W Hart
Journal:  Biochim Biophys Acta       Date:  2006-05-06

8.  Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis.

Authors:  Lina Basel-Vanagaite; Liora Muncher; Rachel Straussberg; Metsada Pasmanik-Chor; Michal Yahav; Limor Rainshtein; Christopher A Walsh; Nurit Magal; Ellen Taub; Valerie Drasinover; Hanna Shalev; Revital Attia; Gideon Rechavi; Amos J Simon; Mordechai Shohat
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

9.  Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.

Authors:  Gabriele Schilling; Alena V Savonenko; Alexandra Klevytska; Johanna L Morton; Stina M Tucker; Michelle Poirier; Alexa Gale; Ning Chan; Vicky Gonzales; Hilda H Slunt; Michael L Coonfield; Nancy A Jenkins; Neal G Copeland; Christopher A Ross; David R Borchelt
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

10.  Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.

Authors:  S T Suhr; M C Senut; J P Whitelegge; K F Faull; D B Cuizon; F H Gage
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  117 in total

Review 1.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

2.  Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.

Authors:  Ke Zhang; J Gavin Daigle; Kathleen M Cunningham; Alyssa N Coyne; Kai Ruan; Jonathan C Grima; Kelly E Bowen; Harsh Wadhwa; Peiguo Yang; Frank Rigo; J Paul Taylor; Aaron D Gitler; Jeffrey D Rothstein; Thomas E Lloyd
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

3.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

4.  TorsinA dysfunction causes persistent neuronal nuclear pore defects.

Authors:  Samuel S Pappas; Chun-Chi Liang; Sumin Kim; CheyAnne O Rivera; William T Dauer
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

Review 5.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

Review 6.  Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.

Authors:  Baljit S Khakh; Vahri Beaumont; Roger Cachope; Ignacio Munoz-Sanjuan; Steven A Goldman; Rosemarie Grantyn
Journal:  Trends Neurosci       Date:  2017-05-31       Impact factor: 13.837

Review 7.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Fractionation for Resolution of Soluble and Insoluble Huntingtin Species.

Authors:  Joseph Ochaba; Eva L Morozko; Jacqueline G O'Rourke; Leslie M Thompson
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

9.  Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice.

Authors:  Eva L Morozko; Joseph Ochaba; Sarah J Hernandez; Alice Lau; Isabella Sanchez; Iliana Orellana; Lexi Kopan; Joshua Crapser; Janet H Duong; Julia Overman; Silvia Yeung; Joan S Steffan; Jack Reidling; Leslie M Thompson
Journal:  J Huntingtons Dis       Date:  2018

10.  The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.

Authors:  Vivian Chen; Malik Moncalvo; Dominic Tringali; Lidia Tagliafierro; Ahila Shriskanda; Ekaterina Ilich; Wendy Dong; Boris Kantor; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.